These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16990336)

  • 1. Benign prostatic hyperplasia: caveat for finasteride should be discussed before prescribing.
    Ammar H; Malani AK; Gupta C
    BMJ; 2006 Sep; 333(7569):654; author reply 654. PubMed ID: 16990336
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of men on finasteride.
    Gormley GJ
    Semin Urol Oncol; 1996 Aug; 14(3):139-44. PubMed ID: 8865475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].
    Hausmann R; Thalmann G; Reich O; Steif CG
    Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of finasteride on prostate specific antigen: review of available data.
    Guess HA; Gormley GJ; Stoner E; Oesterling JE
    J Urol; 1996 Jan; 155(1):3-9. PubMed ID: 7490873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing prostate cancer. Finasteride shrinks enlarged prostates and may prevent some cases of prostate cancer. But it's no panacea.
    Beer TM
    Health News; 2003 Aug; 9(8):1-2. PubMed ID: 12971313
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of finasteride on the percentage of free PSA: implications in the early diagnosis of prostatic cancer].
    Morote J; Lorente JA; Raventós CX; López MA; Encabo G; De Torres I; López M; De Torres JA
    Actas Urol Esp; 1998; 22(10):835-9. PubMed ID: 9949572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Finasteride and prostate cancer].
    Ruutu M; Rannikko A
    Duodecim; 2004; 120(5):525-7. PubMed ID: 15060988
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemoprevention of prostate cancer.
    Walsh PC
    N Engl J Med; 2010 Apr; 362(13):1237-8. PubMed ID: 20357287
    [No Abstract]   [Full Text] [Related]  

  • 9. New finasteride trial results aim to curb controversy.
    Bankhead C
    J Natl Cancer Inst; 2006 Aug; 98(16):1104-5. PubMed ID: 16912260
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate cancer prevention and finasteride.
    D'Amico AV; Barry MJ
    J Urol; 2006 Nov; 176(5):2010-2; discussion 2012-3. PubMed ID: 17070238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution of the PCPT from clinical to molecular analyses.
    Hoque A
    Nat Clin Pract Oncol; 2006 Nov; 3(11):581. PubMed ID: 17080169
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of finasteride on serum PSA concentration in men with benign prostatic hyperplasia. Results from the North American phase III clinical trial.
    Guess HA; Heyse JF; Gormley GJ; Stoner E; Oesterling JE
    Urol Clin North Am; 1993 Nov; 20(4):627-36. PubMed ID: 7505970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Proscar prevent prostate cancer?
    Johns Hopkins Med Lett Health After 50; 2008 Oct; 20(8):3. PubMed ID: 18958922
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug treatment for benign prostatic hyperplasia. To interpret PSA concentrations in patients taking finasteride, multiply them by two.
    Taneja S
    BMJ; 1997 Aug; 315(7104):371. PubMed ID: 9270475
    [No Abstract]   [Full Text] [Related]  

  • 15. Early diagnosis of prostate cancer in finasteride treated BPH patients.
    Tarle M; Kraus O; Trnski D; Reljic A; Ruzic B; Katusic J; Spajic B; Kusic Z
    Anticancer Res; 2003; 23(1B):693-6. PubMed ID: 12680169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatment for benign prostatic hyperplasia. Several trials have shown benefit of finasteride.
    Collins GN
    BMJ; 1997 Aug; 315(7104):371. PubMed ID: 9270474
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting.
    Keetch DW; Andriole GL; Ratliff TL; Catalona WJ
    Urology; 1997 Dec; 50(6):901-5. PubMed ID: 9426721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finasteride may prevent prostate cancer.
    Thompson CA
    Am J Health Syst Pharm; 2003 Aug; 60(15):1511, 1515. PubMed ID: 12951749
    [No Abstract]   [Full Text] [Related]  

  • 19. What's wrong with chemoprevention of prostate cancer?
    Justman S
    Am J Bioeth; 2011 Dec; 11(12):21-5. PubMed ID: 22146025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term results of proscar (finasteride, MSD) treatment of patients with benign prostatic hyperplasia].
    Tkachuk VN; Al'-Shukri SKh; Kornienko VI; Kuz'min IV
    Urol Nefrol (Mosk); 1998; (4):37-9. PubMed ID: 9727320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.